The test is the last of three multiplex bloodstream infection panels that the firm has designed for its Liaison Plex molecular testing instrument.

Current methods of antibody detection, such as conventional serological assays, are limited in terms of the amount of ...

The collaboration will put together the MoxiePlex multiplex fluorescence technology with InSituPlex, Vizgen's proprietary sample preparation technique in which a mixture of antibodies are "barcoded" ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze ...

Heart diseases found widest range as a cause of death worldwide, which raised the demand for early diagnosis with a high degree of accuracy thereby raised the demand for effective, fast with low cost ...

A new EU consortium has launched with the aim to reduce pancreatic cancer mortality rate across the continent.

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a ...

Based on these findings, we recommend the incorporation of multiplex rapid tests into clinical care, whether they may be in the form of immunochromatographic or molecular assays. Testees’ high ...

Vizgen, Inc., a life sciences company advancing spatial multi-omics, today announced a strategic partnership with Hamamatsu Photonics K.K., a global leader in optical imaging technology. This ...

Recent advances in molecular allergology have transformed allergy diagnostics through innovative approaches in allergen characterization, including allergen ...

Report Ocean has published a new report on the Saudi Arabia Tumor Markers Testing Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...